Phase I Study of Dasatinib (BMS-354825) and Capecitabine for Women With Advanced Breast Cancer

Clinical trial NCT00452673 · COMPLETED

Trial details

NCT number: NCT00452673
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Breast Cancer

Start date: 2007-06-01
Primary completion: 2012-10-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.